Teradyne, Ouster, and PROCEPT BioRobotics are the three Robotics stocks to watch today, according to MarketBeat's stock screener tool. Robotics stocks are shares of publicly traded companies whose core business involves designing, manufacturing, selling, or enabling robots and automation systems — including industrial and service robots, robotic components (sensors, actuators, controllers), and the software that controls them. For investors, they provide exposure to the growth of automation across areas like manufacturing, logistics, healthcare, and agriculture and can range from pure-play robotics firms to large diversified companies with robotics divisions, carrying both growth potential and risks from technological change and economic cycles. These companies had the highest dollar trading volume of any Robotics stocks within the last several days.
Teradyne (TER)
Teradyne, Inc. designs, develops, manufactures, and sells automated test systems and robotics products worldwide. It operates through four segments; Semiconductor Test, System Test, Robotics, and Wireless Test. The Semiconductor Test segment offers products and services for wafer level and device package testing of semiconductor devices in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game, and other applications.
Read Our Latest Research Report on TER
Ouster (OUST)
Ouster, Inc. provides lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries in Americas, the Asia-Pacific, Europe, the Middle East, and Africa. Its products include high-resolution scanning and solid-state digital lidar sensors, analog lidar sensors, and software solutions.
Read Our Latest Research Report on OUST
PROCEPT BioRobotics (PRCT)
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH).
Read Our Latest Research Report on PRCT
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Teradyne, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teradyne wasn't on the list.
While Teradyne currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
